Anadys Forms Collaboration With Gilead

Anadys Pharmaceuticals, Inc. and Gilead Sciences, Inc. have entered into a collaboration to discover novel antiviral compounds. As part of the collaboration agreement, Anadys will design, configure and run uHTS-ATLAS screens against a key viral target selected by Gilead. This agreement leverages Anadys’ powerful ability to screen for small molecules that bind to proteins that Read more about Anadys Forms Collaboration With Gilead[…]